Genetic Leap Employee Directory
Biotechnology ResearchNew York, United States2-10 Employees
Genetic Intelligence, Inc. is a clinical-stage biotechnology company based in New York City focused on AI-enabled RNA genetic medicines for in vivo reprogramming delivered as oral therapies. Its approach seeks to reprogram RNA either at the sequence level with oligonucleotides or at the structure level with small molecules, aiming to produce drugs that are safe and efficacious. By treating RNA as the central orchestrator of biology, the company targets diseases for which modern medicine has offered limited solutions. The firm has established collaborations with large pharmaceutical companies to advance genetic medicine therapeutics, including a partnership with Eli Lilly. With a relatively small team, it operates within the biotechnology research sector and maintains a public presence at its website.